Vaccine Head/ Director, Japan Real-World Evidence & Health Outcomes Research

Position Summary

At GSK, we are uniting science, technology, and talent to get ahead of disease together. The Director of RWE-HO Japan leads the local evidence strategy of a dedicated therapeutic area (TA) to demonstrate the value of GSK’s innovative medicines/ vaccines. This role ensures local real-world clinical, economic and humanistic evidence supports regulatory, reimbursement, and patient access objectives, while guiding a high-performing team aligned with GSK’s global evidence standards and Japan’s payer environment.

Key Responsibilities

Strategic Leadership

• Partner with Medical team for robust gap assessment to better understand local unmet needs.
• Participate in Global DGTs and co-create global DGPs representing interests of Japan market needs.
• With solid understanding of the Japan health care system and policy landscape, develop and implement forward-looking Japan-specific RWE and HEOR strategies across GSK’s priority therapeutic areas (e.g., specialty/ oncology/ vaccines/ respiratory) for addressing evidential gaps.
• Identify and address capability gaps to prepare teams for future competitive advantage.
• Ensure evidence supports product value propositions across the lifecycle, including but not limited to optimal listing, re-pricing, HTA engagement, post launch re-examination and outcomes demonstration aligned with GSK’s patient and access goals.

Evidence Generation & Execution

• Ensure that team members engage closely with Japan and global cross-functional stakeholders to plan, design and execute data generation plans (DGPs) for priority assets.
• Lead/ drive prioritised local RWE and Health Outcomes studies, as well as local adaptation of global economic models and support CEE/ HTA submission planning and execution.
• Oversee publications and presentations of study findings at national and international forums.

Cross-Functional Collaboration

• Partner with Market Access, Government Affairs, Medical, Regulatory, and Commercial teams to ensure evidence is aligned with brand strategy and payer needs.
• Represent Japan in global data generation working groups to ensure country insights inform development-stage and post-launch evidence plans.

External Engagement

• Cultivate partnerships with academic institutions, KOLs, and data providers in Japan.
• Contribute to scientific, payer and HTA engagement by translating evidence into clear, locally relevant value messages.

Team & Capability Development

• Manage, mentor, and develop a team of RWE/HEOR professionals.
• Build functional excellence and capability in evidence generation, study design, value communication, and policy awareness.
• Foster a culture of scientific integrity, innovation, and collaboration.

Qualifications

• Advanced degree in science, epidemiology, health economics, public health, biostatistics, or related discipline.
• 8+ years of experience in RWE, HEOR, or Market Access within Japan’s pharmaceutical, biotech, or consulting environment.
• Knowledgeable of Japan’s HTA system, Chuikyo processes, and healthcare policy landscape.
• Proven experience designing and delivering impactful RWE/HEOR projects in Japan (regional/ global experience a plus).
• Track record of team leadership, coaching, and talent development.
• Business-level Japanese and English proficiency.
• Strategic mindset with strong communication and collaboration skills.
• Alignment with GSK values: patient focus, integrity, transparency, and respect.